IFM 2005-01: Velcade/Dexamethasone Versus Vincristine/Adriamycin (Doxorubicin)/Dexamethasone (VAD) for the Treatment of Patients With Multiple Myeloma
NCT00200681
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
493
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
Velcade
Sponsor
Nantes University Hospital